Fig. 3
From: A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
The signature and common clinicopathologic characteristics. a-c Distribution of the signature in patients of TCGA stratified by IDH status (a), MGMT promoter methylation (b), and TCGA subtypes (c). ***P < 0.001, ****P < 0.0001. d-f Distribution of the signature in patients of CGGA stratified by IDH status (d), MGMT promoter methylation (e), and TCGA subtypes (f). ***P < 0.001, ****P < 0.0001